KELSEY JACKSON: Open Payments
NPI 1376046607 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 23 payments from 9 companies in 2025. Trend: 2023 $424 · 2024 $438 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $145 |
| Boston Scientific Corporation | 2 | $143 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $134 |
| AstraZeneca Pharmaceuticals LP | 4 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Novo Nordisk Inc | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Amgen Inc. | 2 | $29 |
Products named: WATCHMAN FLX, LifeVest, CAMZYOS, FARXIGA, ELIQUIS, Kerendia, LEQVIO, Wegovy.
Industry payments across KS — which companies pay providers there.
